Lv2
190 积分 2024-11-26 加入
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
2个月前
已完结
Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy
2个月前
已完结
Integrating multiple sclerosis guidelines into practice
2个月前
已完结
AAN unveils new guidelines for MS disease-modifying therapy
2个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
2个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
2个月前
已完结
Developing cell therapies for lupus
2个月前
已完结
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosis
2个月前
已完结
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
2个月前
已完结
皖公网安备34019202002308
